Yantai Dongcheng Pharmaceutical Group Co.,Ltd. (SHE: 002675)
China
· Delayed Price · Currency is CNY 13.50
-0.18 (-1.32%)
Nov 15, 2024, 3:04 PM CST
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 2,844 | 3,267 | 3,565 | 3,897 | 3,402 | 2,970 | Upgrade
|
| Other Revenue | 8.24 | 8.24 | 18.34 | 15.02 | 16.85 | 22.49 | Upgrade
|
| Revenue | 2,853 | 3,276 | 3,583 | 3,912 | 3,419 | 2,993 | Upgrade
|
| Revenue Growth (YoY) | -16.75% | -8.58% | -8.41% | 14.42% | 14.24% | 28.29% | Upgrade
|
| Cost of Revenue | 1,646 | 1,922 | 2,051 | 2,324 | 1,756 | 1,218 | Upgrade
|
| Gross Profit | 1,206 | 1,354 | 1,532 | 1,588 | 1,663 | 1,775 | Upgrade
|
| Selling, General & Admin | 683.78 | 754.41 | 785.29 | 802.41 | 889.04 | 998.19 | Upgrade
|
| Research & Development | 226.35 | 197.22 | 163.52 | 137.56 | 109.39 | 88.71 | Upgrade
|
| Other Operating Expenses | 50.44 | 33.87 | 29.19 | 33.34 | 30.95 | 31.98 | Upgrade
|
| Operating Expenses | 972.76 | 980.36 | 980.56 | 974.77 | 1,038 | 1,121 | Upgrade
|
| Operating Income | 233.57 | 373.73 | 551.72 | 612.99 | 625.11 | 653.47 | Upgrade
|
| Interest Expense | -80.35 | -44.32 | -58.64 | -56.45 | -47.8 | -46.04 | Upgrade
|
| Interest & Investment Income | 7.01 | 12.78 | 13.2 | 5.12 | 12.25 | 21.04 | Upgrade
|
| Currency Exchange Gain (Loss) | 15.25 | 15.25 | 42.65 | -4.08 | -3.67 | -2.7 | Upgrade
|
| Other Non Operating Income (Expenses) | -41.04 | -13.61 | -5.94 | -2.58 | -3.69 | -14.59 | Upgrade
|
| EBT Excluding Unusual Items | 134.44 | 343.82 | 542.97 | 555 | 582.2 | 611.18 | Upgrade
|
| Impairment of Goodwill | - | - | -80.1 | -211.26 | - | -172.37 | Upgrade
|
| Gain (Loss) on Sale of Investments | -34.81 | -28.13 | -39.21 | -12.15 | 1.05 | -67.75 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.18 | -0.23 | -0.38 | -0.15 | -1.29 | 10.63 | Upgrade
|
| Asset Writedown | 2.03 | 0.04 | - | -0.16 | -0.32 | -0.24 | Upgrade
|
| Other Unusual Items | 37.32 | 21.77 | 22.3 | 24.82 | 29.74 | 14.31 | Upgrade
|
| Pretax Income | 138.8 | 337.28 | 445.58 | 356.1 | 611.37 | 395.76 | Upgrade
|
| Income Tax Expense | 73.62 | 83.07 | 92.75 | 95.25 | 93.9 | 102.12 | Upgrade
|
| Earnings From Continuing Operations | 65.18 | 254.22 | 352.83 | 260.85 | 517.47 | 293.64 | Upgrade
|
| Minority Interest in Earnings | 25.62 | -44.48 | -45.54 | -109.29 | -99.71 | -138.93 | Upgrade
|
| Net Income | 90.79 | 209.74 | 307.29 | 151.56 | 417.77 | 154.71 | Upgrade
|
| Net Income to Common | 90.79 | 209.74 | 307.29 | 151.56 | 417.77 | 154.71 | Upgrade
|
| Net Income Growth | -65.45% | -31.75% | 102.75% | -63.72% | 170.02% | -44.83% | Upgrade
|
| Shares Outstanding (Basic) | 825 | 825 | 808 | 802 | 802 | 802 | Upgrade
|
| Shares Outstanding (Diluted) | 825 | 825 | 808 | 802 | 802 | 802 | Upgrade
|
| Shares Change (YoY) | 0.01% | 2.10% | 0.68% | 0.02% | 0.02% | 5.79% | Upgrade
|
| EPS (Basic) | 0.11 | 0.25 | 0.38 | 0.19 | 0.52 | 0.19 | Upgrade
|
| EPS (Diluted) | 0.11 | 0.25 | 0.38 | 0.19 | 0.52 | 0.19 | Upgrade
|
| EPS Growth | -65.45% | -33.15% | 101.38% | -63.73% | 169.97% | -47.85% | Upgrade
|
| Free Cash Flow | -167.19 | -235 | 606.93 | 413.42 | 310.39 | 446.3 | Upgrade
|
| Free Cash Flow Per Share | -0.20 | -0.28 | 0.75 | 0.52 | 0.39 | 0.56 | Upgrade
|
| Dividend Per Share | 0.125 | 0.125 | 0.150 | 0.150 | 0.250 | 0.250 | Upgrade
|
| Dividend Growth | -16.67% | -16.67% | 0% | -40.00% | 0% | 420.83% | Upgrade
|
| Gross Margin | 42.29% | 41.34% | 42.77% | 40.59% | 48.65% | 59.31% | Upgrade
|
| Operating Margin | 8.19% | 11.41% | 15.40% | 15.67% | 18.28% | 21.83% | Upgrade
|
| Profit Margin | 3.18% | 6.40% | 8.58% | 3.87% | 12.22% | 5.17% | Upgrade
|
| Free Cash Flow Margin | -5.86% | -7.17% | 16.94% | 10.57% | 9.08% | 14.91% | Upgrade
|
| EBITDA | 378.49 | 508.13 | 672.09 | 727.92 | 727.85 | 749.52 | Upgrade
|
| EBITDA Margin | 13.27% | 15.51% | 18.76% | 18.61% | 21.29% | 25.04% | Upgrade
|
| D&A For EBITDA | 144.92 | 134.4 | 120.37 | 114.93 | 102.74 | 96.05 | Upgrade
|
| EBIT | 233.57 | 373.73 | 551.72 | 612.99 | 625.11 | 653.47 | Upgrade
|
| EBIT Margin | 8.19% | 11.41% | 15.40% | 15.67% | 18.28% | 21.83% | Upgrade
|
| Effective Tax Rate | 53.04% | 24.63% | 20.82% | 26.75% | 15.36% | 25.80% | Upgrade
|
| Revenue as Reported | 2,853 | 3,276 | 3,583 | 3,912 | 3,419 | 2,993 | Upgrade
|
| Advertising Expenses | - | 1.06 | 0.83 | 0.29 | 0.15 | 0.26 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.